Patient Conditions which may

benefit from 

Anodyne Therapy

 Acute and chronic
sprain /strain injuries - knee, elbow wrist ankle    cervical, thoracic
and lumbar spine.
 

Painful restricted
range of motion-
thoracic and lumbar
spine.
 

Musculoskeletal
pain – thoracic and
lumbar spine

Peripheral Neuropathy.
 

Degenerative disc
disease.
 

Facet syndrome/
periarticular fibrosis
 

Disc protrusions.

Diabetes.

Post surgical
laminectomies.
 

Spinal fusions with
instrumentation.

Acute & Chronic Carpal Tunnel Syndrome.
 

The history of the Anodyne Therapy System began in 1992 with a vision to provide greater effectiveness and a more friendly application of Infrared Therapy, with minimal risk. Effectiveness is accomplished by creating an interface previously unheard of in traditional infrared therapy devices. Our equipment is in direct contact with the area to be treated. The unique patented flexible infrared therapy pads allow the pads to contour without excessive pressure dictating a continuous perpendicular application of the modality.

As long as proper professional application guidelines and enclosed instructions are followed, the Anodyne Therapy System presents minimal risk. Normal precautions for any type of therapy, as well as precautions outlined in the Anodyne Therapy Use Manual, should always be used. However, the relatively short treatment times and the generally quick response to care, give additional margins of safety.

Patents on this technology and United States Food and Drug Administration (FDA) 510K clearance was granted March 30th, 1994. Our primary focus is on diabetic peripheral neuropathy (DPN). Through research and application, we hope to set a new standard in treatment of DPN by restoring sensation that was previously lost.

Anodyne Therapy is an FDA-approved light-emitting device that speeds the healing of wounds, even in difficult to treat diabetic ulcers. There are 16 million diabetics and others in this nation who could benefit from this new innovative technology.

More exciting news is a current study testing the device on diabetic neuropathy (loss of sensation or feeling), a previously irreversible condition that often leads to amputation. A joint study conducted at three Colorado medical centers followed 49 diabetics with type 1 or type 2 diabetes who had peripheral neuropathy in their feet. Most showed improvement after six thirty minute treatments. After 12 treatments, all had improved responses to standard tests that measure the impairment of sensation in diabetics, and their risk of amputation was greatly reduced. The study was presented last year at the American Diabetes Association Scientific Sessions.

How does it work? Sixty light-emitting diodes are fitted into flexible pads that can be applied directly to the skin or any part of the body. When the monochromatic near-infrared photo (light) energy device - MIRE for short - is applied directly to the skin, the light energy helps release small molecules of nitric oxide from hemoglobin in the bloodstream. Nitric oxide increases blood flow and helps deliver healing cells and nutrients to the treatment area.

In addition to treating wounds (even surgical wounds that heal too slowly) and neuropathy, it's been used on arthritis, fractures, bursitis and tendinitis. No side effects have been reported, but the device is not recommended for people who may be pregnant or who have active cancer.
 

Sophisticated options for
prescribed treatment.
 

User friendly control and
operation.
 

Optimum patient safety and
comfort.